Estrogen‐metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women

Genes encoding enzymes involved in estrogen metabolism are held to be candidate genes for associations with breast disease. In these candidate genes, no critical combination of single‐nucleotide polymorphisms (SNPs) for assessing breast carcinoma risk has been reported to date.

[1]  J. Freudenheim,et al.  Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. , 1998, Cancer research.

[2]  D. Hunter,et al.  Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density , 2004, Breast Cancer Research and Treatment.

[3]  B. Weber,et al.  Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer. , 2003, Cancer research.

[4]  B. Ponder,et al.  Effect of germ-line genetic variation on breast cancer survival in a population-based study. , 2002, Cancer research.

[5]  W. Willett,et al.  The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. , 1999, Cancer research.

[6]  S J London,et al.  A prospective study of benign breast disease and the risk of breast cancer. , 1992, JAMA.

[7]  P. Lønning,et al.  Genetic variants of CYP19 (aromatase) and breast cancer risk , 2000, Breast Cancer Research.

[8]  S. Wingren,et al.  Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women , 2001, British Journal of Cancer.

[9]  N. Roodi,et al.  Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. , 2000, Cancer research.

[10]  A. V. Peterson,et al.  Risk of breast cancer in women with benign breast disease. , 1980, Journal of the National Cancer Institute.

[11]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[12]  R. Gelber,et al.  Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Hirahara,et al.  Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women. , 2003, The Journal of clinical endocrinology and metabolism.

[14]  M. W. Mueller,et al.  Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. , 2002, Analytical biochemistry.

[15]  G. Chetrite,et al.  Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma , 1997, International journal of cancer.

[16]  E. Taioli,et al.  A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. , 1995, Cancer research.

[17]  M. Khoury,et al.  Population screening in the age of genomic medicine. , 2003, The New England journal of medicine.

[18]  Y. Miyoshi,et al.  Breast Cancer Risk Associated with CYP1A1 Genetic Polymorphisms in Japanese Women , 2002, The breast journal.

[19]  J. Freudenheim,et al.  Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.

[20]  S. Garte.  The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. , 1998, Carcinogenesis.

[21]  B. Ponder,et al.  Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. , 2001, Carcinogenesis.

[22]  B. Henderson,et al.  Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. , 2003, Cancer research.

[23]  Chen-Yang Shen,et al.  Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. , 1999, Cancer research.

[24]  R. Service.  New Role for Estrogen in Cancer? , 1998, Science.

[25]  W. Tan,et al.  CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. , 2001, Carcinogenesis.

[26]  C. V. de Moura Gallo,et al.  CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. , 2002, Cancer letters.